- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 04.03. | Bluebird Kids Health Raises $31.5M for Its Value-Based Pediatric Care Clinics in Underserved Areas | ||
| 04.03. | VC Firm Sofinnova Partners Pulls In €1.2B to Deploy Across Life Sciences Investments | ||
| 04.03. | One Year Post-Change Healthcare Cyber Attack: What Keeps This Healthcare CTO Awake at Night | ||
| 04.03. | Data Clean Rooms: The Secret to Secure Healthcare Data Sharing | ||
| 04.03. | 'Innovation Out of Necessity': Why Virtual Care Is Crucial for Rural Providers | ||
| 04.03. | Sonder Health Plans Taps Cleo for Care Coordination & Family Caregiving Support | ||
| 03.03. | AbbVie Enters Obesity Field, Paying $350M for Amylin Receptor Agonist Already in the Clinic | ||
| 03.03. | Imagine Advanced Digital Surgery, Anywhere, for Everyone | ||
| 03.03. | Building Service Infrastructure for "Made-To-Order" Therapies | ||
| 02.03. | 5 Notable Health Tech Funding Announcements in February | ||
| 02.03. | Praxis Presses Forward in Essential Tremor Despite Futility Finding From Trial Observers | ||
| 02.03. | Why Retail Health Giants Are Failing in Primary Care | ||
| 02.03. | The Promise and Peril of Price Transparency Under Trump's New Executive Order | ||
| 02.03. | Empowering Community Health Workers: The Unsung Heroes Transforming Healthcare | ||
| 28.02. | BridgeBio Oncology to Go Public in SPAC Deal Bringing $450M+ for Trio of Cancer Drugs | ||
| 28.02. | MedCity Pivot Podcast: Being Clear About Cybersecurity | ||
| 28.02. | MedCity FemFwd: Why Infertility Isn't Just a Women's Issue | ||
| 28.02. | Tia Teams Up with Nourish to Provide Nutrition Support to Women | ||
| 28.02. | Health Economics and Outcomes Research: Biopharma's Underappreciated Value Creator | ||
| 28.02. | Biocompatible Nanoparticles: Tiny Antennae with Huge Potential for Brain-Computer Interfaces | ||
| 28.02. | A Startup Provides Physician-led Virtual Visits for Women at Risk for Heart Disease | ||
| 28.02. | UnitedHealth Hit with 2 New Federal Probes in 1 Week | ||
| 27.02. | Trump's IVF Executive Order Doesn't Actually Achieve Much - Yet | ||
| 27.02. | Rare Disease Biotech Zevra Therapeutics to Sell FDA Drug Review Fast Pass for $150M | ||
| 27.02. | Whole Blood: The Next Frontier for EMS |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
